AzTrials
AzTrials

Cerebral PalsyNCT03681171

Therapeutic Dance Intervention for Children With Cerebral Palsy

A study testing Therapeutic Dance in people with Cerebral Palsy, run by Shlomit Aizik.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Children with cerebral palsy (CP) have motor impairments that may limit participation in standard physical activity (PA) programs. Adapted PA interventions may help address this gap. Dance-based interventions may support coordination, posture, muscle strength, motor learning, and executive function. Read more about this study

Who is it for?
Ages 9 to 15 years
Conditions the study is for
Cerebral Palsy
What is being tested?
Therapeutic Dance
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
No sites listed yet
Study dates
6 Oct 2016to 15 Jun 2017
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 9 to 15 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Cerebral palsy spastic diplegia and/or hemiplegia
  • Absence of health problems that would preclude participation in exercise
  • Male or female age 9 - 15 years inclusive at the time of consent
  • Minimum level of intellectual functioning (e.g., as determined by an IQ score of 80 or above or other education placement and testing indicating sufficient understanding)
  • Ability to complete study measures at the assessment
  • Ability to participate in dance classes conducted in English
Show all 13Show fewer
  • Interest in learning ballet
  • Intact vision
  • Intact hearing
  • Able to ambulate independently in the community with or without a device
  • Intact proprioception in lower extremities
  • Able to complete assessment measures and consents in English
  • Referral from the child's pediatrician or other physician indicating that the child is physically able to participate in an exercise intervention

Who cannot join

  • Children with a current diagnosis of severe Major Depressive Disorder
  • Generalized Anxiety Disorder
  • Epilepsy
  • Autism
  • Other major medical conditions that prohibit full participation and children with severe developmental disorders (e.g., mental retardation, severe autism) or with physical impairments that prohibit full participation were excluded from the study.

About this study

Official title: A Pilot Study of a Therapeutic Dance Intervention for Children With Cerebral Palsy

Children with cerebral palsy (CP) have motor impairments that may limit participation in standard physical activity (PA) programs. Adapted PA interventions may help address this gap. Dance-based interventions may support coordination, posture, muscle strength, motor learning, and executive function. This pilot study evaluates the feasibility and preliminary effects of a therapeutic ballet intervention designed for children with CP on physiological and executive function outcomes.

Read the detailed description

Eight children with cerebral palsy (CP), ages 9 to 14 years, participated in a six-week therapeutic ballet intervention. Participants underwent pre- and post-intervention assessments of body composition by dual-energy X-ray absorptiometry (DXA), muscle strength by hand-grip dynamometry, habitual physical activity, gait, selective motor control, and executive function. Follow-up assessments of habitual physical activity, gait, and executive function were completed 4 to 5 weeks after the intervention.

Conditions
Cerebral Palsy
Being tested
Therapeutic Dance
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Therapeutic DanceOther

    Participants attended therapeutic ballet sessions three times per week for six weeks.

Study groups in NCT03681171
Study groupRoleWhat they receive
Children with CPExperimentalChildren with CP (9-15 years old) participated in a therapeutic dance program to improve physical, physiological and cognitive outcomes.
Receives: Other: Therapeutic Dance

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Congruent Trial (Hearts) Accuracy

    Inhibitory control, working memory, and cognitive flexibility (hearts and flowers computer task) The scale title is Accuracy (%) and the measurement is percent correct, where the higher scores mean better results and more accuracy. Accuracy ranges from about 20%-100%

    Measured: 12 weeks

  2. Congruent Trial (Hearts) Response Time

    Inhibitory control, working memory, and cognitive flexibility (hearts and flowers computer task) The scale title is Response Time in milliseconds (ms), the lower the number the better the score. The range is about 550ms-1100ms.

    Measured: 12 weeks

  3. Incongruent Trial (Flowers) Accuracy

    Inhibitory control, working memory, and cognitive flexibility (hearts and flowers computer task) The scale title is Accuracy (%) and the measurement is percent correct, where the higher scores mean better results and more accuracy. Accuracy ranges from about 20%-100%

    Measured: 12 weeks

  4. Incongruent Trial (Flowers) Response Time

    Inhibitory control, working memory, and cognitive flexibility (hearts and flowers computer task) The scale title is Response Time in milliseconds (ms), the lower the number the better the score. The range is about 550ms-1100ms.

    Measured: 12 weeks

  5. Mixed Trial (Hearts and Flowers) Accuracy

    Inhibitory control, working memory, and cognitive flexibility (hearts and flowers computer task) The scale title is Accuracy (%) and the measurement is percent correct, where the higher scores mean better results and more accuracy. Accuracy ranges from about 20%-100%

    Measured: 8 weeks

  6. Mixed Trial (Hearts and Flowers) Response Time

    Inhibitory control, working memory, and cognitive flexibility (hearts and flowers computer task) The scale title is Response Time in milliseconds (ms), the lower the number the better the score. The range is about 550ms-1100ms.

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Sep 2018
  2. Study start6 Oct 2016
  3. Primary completion15 Jun 2017
  4. Study completion15 Jun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03681171
Sponsor's protocol ID
20162682
Status last verified
Jan 2025
First submitted
30 Aug 2018
Last updated
12 Mar 2026
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lakes KD, Sharp K, Grant-Beuttler M, Neville R, Haddad F, Sunico R, Ho D, Schneider M, Sawitz S, Paulsen J, Caputo K, Lu KD, Aminian A, Lopez-Ortiz C, Radom-Aizik S. A Six Week Therapeutic Ballet Intervention Improved Gait and Inhibitory Control in Children With Cerebral Palsy-A Pilot Study. Front Public Health. 2019 Jun 25;7:137. doi: 10.3389/fpubh.2019.00137. eCollection 2019.

    PubMed 31294009

Questions about this trial

What is this clinical trial studying?

A study testing Therapeutic Dance in people with Cerebral Palsy, run by Shlomit Aizik.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 13 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 12 Mar 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Congruent Trial (Hearts) Accuracy (time frame: 12 weeks). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03681171, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in